Clinical predictors of high risk histopathology in retinoblastoma

Pediatric Blood and Cancer

Volumn 58, Issue 3, 2012, Pages 356-361

  Kashyap, Seema ^a,c,f   Meel, Rachna ^b,c,f   Pushker, Neelam ^b,c,f   Sen, Seema ^a,c,f   Bakhshi, Sameer ^d,e,f   Sreenivas, Vishnubhatla ^d,f   Sethi, Sumita ^b,c,f   Chawla, Bhavna ^b,c,f   Ghose, Supriyo ^b,c,f  

^a Ocular Pathology Services   (India)

^b Oculoplastics and Orbit Services   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d Department of Medical Oncology ^*  (India)

^e INSTITUTE ROTARY CANCER HOSPITAL   (India)

^f ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Clinical predictors; High risk histopathology; Retinoblastoma

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER INVASION; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; ENUCLEATION; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPHEMA; INFANT; MAJOR CLINICAL STUDY; MALE; ORBIT CELLULITIS; PREDICTION; PRIORITY JOURNAL; RETINOBLASTOMA; RETROSPECTIVE STUDY; UNIVARIATE ANALYSIS;

ADOLESCENT; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; EYE ENUCLEATION; FEMALE; GLAUCOMA; HUMANS; INDIA; INFANT; MALE; MULTIVARIATE ANALYSIS; NECROSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84855762485     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23239     Document Type: Article

References (14)

1. Linn Murphree A. Intraocular retinoblastoma: The case for a new group classification. Ophthalmol Clin North Am 2005; 18: 453-458.
2. Messmer EP, Heinrich T, Hopping W, et al. Risk factors for metastases in patients with retinoblastoma. Ophthalmology 1991; 98: 136-141.
3. Shields CL, Shields JA, Baez KA, et al. Choroidal invasion of retinoblastoma: Metastatic potential and clinical risk factors. Br J Ophthalmol 1993; 77: 544-548.
4. Shields CL, Shields JA, Baez KA, et al. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer 1994; 73: 692-698.
5. Honavar SG, Singh AD, Shields CL, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol 2002; 120: 923-931.
6. Chantada GL, Casco F, Fandiño AC, et al. Outcome of patients with retinoblastoma and postlaminar optic nerve invasion. Ophthalmology 2007; 114: 2083-2089.
7. Biswas J, Das D, Krishnakumar S, et al. Histopathologic analysis of 232 eyes with retinoblastoma conducted in an Indian tertiary-care ophthalmic center. J Pediatr Ophthalmol Strabismus 2003; 40: 265-267.
8. Orellana ME, Fernandes BF, Arean C, et al. Clinical pathologic study of a cohort of patients with retinoblastoma from a developing country. J Pediatr Ophthalmol Strabismus 2009; 46: 294-299.
9. Chantada GL, Gonzalez A, Fandino A, et al. Some clinical findings at presentation can predict high-risk pathology features in unilateral retinoblastoma. J Pediatr Hematol Oncol 2009; 31: 325-329.
10. Gupta R, Vemuganti GK, Reddy VA, et al. Histopathologic risk factors in retinoblastoma in India. Arch Pathol Lab Med 2009; 133: 1210-1214.
11. Sastre X, Chantada GL, Doz F, et al. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med 2009; 133: 1199-1202.
12. Shangmugam MP, Biswas J, Gopal L, et al. The clinical spectrum and treatment outcome of retinoblastoma in Indian Children. J Pediatr Ophthalmol Strabismus 2005; 42: 75-81.
13. Bakhshi S, Gupta S, Gogia V, et al. Compliance in retinoblastoma. Indian J Pediatr 2010; 77: 535-540.
14. Chong EM, Coffee RE, Chintagumpala M, et al. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Arch Pathol Lab Med 2006; 130: 1669-1672.